FindTrial
Sign In

A clinical study for postoperative delirium, analgesia and inflammatory factors in patients treated with myomectomy by Sufentanil at different times

A clinical study for postoperative delirium, analgesia and inflammatory factors in patients treated with myomectomy by Sufentanil at different times

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019949
Enrollment
Unknown
Registered
2018-12-09
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesia

Interventions

Group 1:Sufentanil was given 1 h before the end of the operation
Group 2:no

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. According to the patient's medical history, combined with ultrasound-assisted diagnosis of uterine fibroids; 2. Patients who are scheduled for myomectomy surgery; 3. Patient ASA I-II; 4. After the operation, the patient is set to the PACU and the stay time is >1h.

Exclusion criteria

Exclusion criteria: (1) Central nervous system diseases and legacy neurological sequelae; (2) History of mental illness; (3) Patients with severe liver and kidney disease; (4) Patients who are unable to communicate normally; (5) Serious adverse reactions such as cardiac arrest and cardiopulmonary resuscitation during surgery; (6) History of alcohol addiction or drug abuse.

Design outcomes

Primary

MeasureTime frame
Heart rate and blood pressure;Sedation/analgesia/delirium score;Inflammatory factor;Hormone change;—

Countries

China

Contacts

Public ContactZHAO BO

Renmin Hospital of Wuhan University

zb14526@163.com+86 13554186345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026